David M. Miller MD, PhD, FAAD

Looking forward to discussing the latest developments in the treatment of #NMSC with Dr. Vishal Patel of GW med at tonight’s @MLG_CME event.

Excited for the upcoming #RMed2023. Always one of my favorite events of the year. Looking forward to presenting StoryboardR - An R Package and Shiny Application Designed to Visualize Real-World Data From Clinical Patient Registries with @SophiaShalhout. #Rstats @r_medicine

Looking forward to hearing from our esteemed panelists @KYTsaiLab and Dr. Michael Migden along with co-chair Dr. Michael K Wong in our upcoming @MedscapeLIVE event: na.eventscloud.com/website/5… It should make for a great discussion.

Great work @statistishdan. The @r_medicine workshop “Simply Reproducible: Clinical Reporting with {gtsummary}” was superb. Missed it live, but caught up via @YouTube youtu.be/p-diyV2E77o. That package is excellent. Represents a ton of work by you & the dev team. #RStats #r4ds

Thanks to ⁦@RMEIMedEd⁩ for hosting a satellite CME symposium ⁦@EADOCongressSEV⁩ on the management of NMSC. And kudos to my co-presenters ⁦@bruindoctor⁩ and Axel Hauschild. You both did a fantastic job.

Great talk @bruindoctor on “Staging and Procedural Management of High Risk Keratinocyte Carcinomas” @AADskin session “What’s New in the Management of Advanced Skin Cancer”. #AAD2022

We provide source code at github.com/TheMillerLab/eLAB as well as examples, and instructions for adaptability for other clinical research projects that aim to collect large-scale laboratory data from the EHR in the paper. 8/n

The EHR-R-REDCap pipeline can be utilized to capture patient data features from participating institutions. Here, we demonstrate #eLAB, the EHR-R-REDCap pipeline utilized by our MCC Registry to capture thousands of laboratory values from the EHR for thousands of subjects 7/n

(3) imports the data in bulk for thousands of patients at a time into Research Electronic Data Capture (REDCap), the electronic data capture system that houses the data. 6/n

Great to see "Clinical utility of cell-free DNA liquid biopsies in Merkel cell carcinoma" out in @Derm_Journal. Appreciate the work & insights of @SophiaShalhout, @HowardK39084949 & #KevinEmerick. We need to continue to innovate on how we care for patients w/#MerkelCellCarcinoma

Unfortunately just a fraction of the cases that present to providers are correctly suspected as MCC. Interestingly cyst, BCC, and SCC were the three most commonly suspected diagnoses prior to biopsy confirmation of MCC. 3/n

Great work @FareesSaqlain, @SophiaShalhout & #KaylaWright for getting "Evaluation of clinical characteristics and pre-biopsy impressions of primary Merkel cell carcinoma of the skin" out in @Derm_Journal today. 1/n 👇

Appreciate the shout out @icymi_r . Please checkout out the paper at themillerlab.io/publication/… and app at github.com/TheMillerLab/Body… and let us know what you think. No doubt the #RStats community can help @SophiaShalhout and me make #BodyMapR even more effective and useful.

MCC tumor burden significantly correlated with the highest cfDNA variant allele fraction. Furthermore, we present a couple of scenarios where liquid biopsies had clinical utility. 7/12

From our twitter poll, it appears that the majority of respondents have yet to order a liquid biopsy for patients with #MerkelCellCarcinoma. Here's a thread discussing a recent study by @SophiaShalhout of the Center for MCC @MGHCancerCenter re: liquid bx in MCC. 1/12

The results are in from our poll: the majority of providers perform staging brain MRIs in #MCC Stage III-IV pts. We recently looked at the utility of initial staging brain MRIs in #MerkelCellCarcinoma. Here's a thread on what @FareesSaqlain of @harvardmed found. 1/11

There has been a rapid proliferation of FDA-approved medications with labeled indications for #psoriasis over the last decade Here's a thread on our recent analysis of the fragility of pivotal trials in psoriasis jaad.org/article/S0190-9622(… 1/10